Project/Area Number |
18K17965
|
Research Category |
Grant-in-Aid for Early-Career Scientists
|
Allocation Type | Multi-year Fund |
Review Section |
Basic Section 59040:Nutrition science and health science-related
|
Research Institution | Shimane University |
Principal Investigator |
Sumiyoshi Eri 島根大学, 学術研究院医学・看護学系, 助教 (40782404)
|
Project Period (FY) |
2018-04-01 – 2021-03-31
|
Project Status |
Completed (Fiscal Year 2020)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2019: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2018: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | テオブロミン / 老化促進モデルマウス / 認知機能 / BDNF / 高齢マウス / SAMP8マウス / mTOR |
Outline of Final Research Achievements |
Theobromine is the primary methylxanthine found in products made from cacao. We previously reported that theobromine intake performed better on learning tasks with enhanced cAMP responsive element binding protein (CREB) / brain-derived neurotrophic factor (BDNF) in normal mice. However, the effect of theobromine intake on cognitive function in age-related learning and memory disorders, such as in senescence-accelerated mouse-prone 8 (SAMP8) mice, is unknown; therefore, we investigated the effects of theobromine intake on learning and memory in a SAMP8 mouse model. As a result, theobromine intake in SAMP8 mice improved short-term learning memory and increased expression of BDNF in the cerebral cortex and hippocampus as compared with the standard diet intake mice. These results suggest that theobromine intake may be effective in improving brain function in SAMP8 mice.
|
Academic Significance and Societal Importance of the Research Achievements |
2025年には、日本の高齢者の5人に1人(約700万人)が認知症を発症すると見込まれる。認知症の約60%がアルツハイマー型である。アルツハイマー病は脳にアミロイドβやタウタンパク質が蓄積し神経細胞が死ぬことで発症すると考えられているが、近年アルツハイマー病による認知機能低下にはmTORシグナルの過剰な活性化の関与が指摘されている。私の研究グループは培養細胞を用いたin vitro研究で、テオブロミンがmTORシグナルを抑制することを報告した。このことから、テオブロミンを含む食品の摂取は、アルツハイマー病などの認知機能低下を予防・治療することが期待できる。
|